Article
ALKBH5 as a therapeutic target for hypertension: Inhibiting vascular smooth muscle cell phenotypic switch via the TEAD3/PDZK1 axis.
Translational research : the journal of laboratory and clinical medicine - 1 Aug 2026
Luo Liying, Wang Lei, Ma Dan, Liu Wenxiu, Shi Zhiyu, Liu Chunnan, Zhao Meng, Bai Yufeng, Lu Jiukun, Chi Jinyu
Abstract excerpt
Hypertension is a chronic disease accompanied by vascular remodeling. As an m6A demethylase, ALKBH5 is implicated in cardiovascular diseases. Herein, we demonstrated that ALKBH5 expression was upregulated in the aortic tissues of spontaneously hypertensive rats (SHR), with predominant localization in vascular smooth muscle cells (VSMCs). To define ALKBH5 function, we generated an SM22α-driven, VSMC-specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
